The first four medications inhibiting SGLT2 to be approved were dapagliflozin, canagliflozin, empagliflozin, and sotagliflozin
Some patients may also experience mild side effects, such as nausea or digestive discomfort, which can temporarily affect their appetite and food intake
When a GLP-1 is the apparent cause, however, an imaging scan of the pancreas isnt needed to confirm a diagnosis, but may be necessary to rule out other causes
Dose adjustments or temporary pauses in escalation can allow your body more time to adapt
At Ideal Face & Body, we offer several surgical solutions, each custom to different needs and concerns
Native rhIGF-1 in IGF-1 Deficiency Chernausek et al., Journal of Clinical Endocrinology & Metabolism (2007) Chernausek and colleagues conducted the pivotal long-term clinical trial of recombinant human IGF-1 (mecasermin) in pediatric patients with severe primary IGF-1 deficiency the trial that supported FDA approval of Increlex for this rare growth-failure population